glp-1 while pregnant Increased Risk of NICU Stays for Babies Born to Mothers Prescribed Medications in the 90 Days Before Pregnancy Using GLP-1 for PMOS and
Description
The city of Boston recently announced it reached an agreement with the group that covers unionized employees and retirees to pull back on nonspecialty drugs, including GLP-1s
Research indicates that patients undergoing GLP-1 therapy lose an average of 10.6% of their total body weight, compared to just 3.9% for those on a placebo
Noninvasive evaluation of GPR119 agonist effects on -cell mass in diabetic male mice using 111 In-exendin-4 SPECT/CT
Neumann, M
Blood glucose monitoring remains important for patients with diabetes taking GLP-1 medications
